SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently trending as members of the 'Shib Army' engage in heated debates over the token's long-term utility versus its status as a speculative meme coin. Community members are actively speculating on the impact of potential token burns and broader ecosystem developments while monitoring price action for signs of a breakout.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently trending due to intense community debate over its sharp decline toward multi-year lows, leaving investors divided between those viewing the price drop as a prime accumulation opportunity and those fearing a potential total collapse. While some holders maintain conviction in the project's institutional adoption and real-world utility, many are actively expressing frustration over the lack of price momentum compared to the broader market.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia Corporation is currently trending as investors closely monitor a highly anticipated court ruling regarding patent litigation, which remains the primary catalyst driving sentiment and volatility for the stock. The community is actively debating the biotech's valuation and long-term potential, with bulls pointing to the strong commercial performance of Yutrepia while skeptics argue the stock is currently overvalued.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is currently trending as investors weigh concerns about rising mortgage rates and cooling housing demand against its role as a defensive, dividend-paying staple. The community is actively debating the stock's long-term potential as a 'safety play' while monitoring critical support levels ahead of upcoming earnings.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

The Direxion Daily TSLA Bull 2X Shares is facing heightened retail scrutiny and volatility as investors debate the sustainability of Tesla's long-term growth and its extreme exposure to the EV manufacturer's recent price action. While some community members view current levels as a deep-value buying opportunity for an eventual reversal, many others are expressing significant caution regarding the inherent risks of holding leveraged ETFs prone to decay.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is trending as investors anticipate a significant pivot toward operational profitability by mid-2026, with the community closely tracking positive prescription script data and upcoming financial reporting. Strong institutional ownership and high short interest have created a volatile setup, with traders actively debating the potential for a short squeeze as the company continues its commercial scaling in the gastrointestinal market.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

BONK is facing significant downward pressure following a governance exploit that allowed an attacker to drain a substantial portion of the project's treasury. Community sentiment is deeply divided, with many long-term holders expressing frustration over the persistent selling and lack of clear communication from the team, while others continue to buy the dip in anticipation of a potential market recovery.

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining is currently attracting significant attention as investors position themselves for potential free cash flow growth following the integration of recent acquisitions. The community is actively discussing the company's operational execution and its role in a broader commodity cycle, with many monitoring its performance alongside broader precious metals sentiment as the stock works to establish a new support level.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc. is facing significant volatility following its recent earnings report, where a headline revenue decline triggered a sharp sell-off despite growth in the high-margin systems integration segment and reiterated EBITDA guidance. Investors remain divided, with bears pointing to stagnant growth and insider selling, while bulls emphasize the company's deepening ties with Dell and potential for long-term AI infrastructure expansion.

Select Sector SPDR Trust (The) - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

XLK is currently navigating a period of consolidation as investors weigh continued cloud and AI growth against valuation concerns and shifting sentiment regarding capital expenditure returns. Community discussion remains focused on potential leadership rotations, monitoring key support levels, and tracking the earnings performance of the mega-cap tech stocks that drive the ETF's trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ecolab Gears Up to Report Q2 Results: How to Play the Stock?

ECL's Q2 results are likely to benefit from strong growth engines and pricing gains, but elevated input costs may test margins and earnings momentum.

IQVIA Gears Up to Report Q2 Earnings: What's in the Offing?

IQV heads into its Q2'26 earnings release with y/y revenue and EPS growth expected, supported by AI adoption, drug launches and high-margin segment gains.

Reasons to Retain Align Technology Stock in Your Portfolio for Now

ALGN's global expansion and iTero innovations support growth, but can they offset currency headwinds and macro pressures?

Can Acute Care Strength Offset Universal Health's Rising Q2 Costs?

UHS heads into Q2 with higher admissions and revenue growth expected, but rising labor and operating costs may limit earnings upside.

Alcon (ALC) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Reasons to Retain Globus Medical Stock in Your Portfolio for Now

GMED is gaining share in musculoskeletal solutions with strong implant and trauma growth, backed by a debt-free balance sheet despite cost and FX pressures.

Labcorp Prepares to Report Q2 Earnings: What's in the Cards?

LH heads into Q2 earnings results with expectations for higher revenues and EPS, as diagnostics, specialty testing and new collaborations drive momentum.

Will Lower Patient Days Affect Tenet Healthcare's Q2 Earnings?

THC's Q2 performance is likely to have witnessed lower patient days, but higher revenue per admission and Ambulatory Care growth could help offset the pressure.

WST Likely to Beat Q2 Earnings Estimates: How to Play the Stock?

WST heads into Q2 earnings with expectations for revenue and EPS growth, backed by demand for biologics and GLP-1 components plus manufacturing gains.

Will Higher Expenses Impact HCA Healthcare's Q2 Earnings?

HCA faces Q2 earnings uncertainty as rising expenses and fewer outpatient surgeries may offset admission growth.

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.

Alcon Inc. - Registered Shares

Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback

Equity

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.76	--	--	N/A
Q1 '26	$0.81	$0.85	4.62%	BEAT
Q4 '25	$0.79	$0.78	-1.01%	MISSED
Q3 '25	$0.76	$0.79	3.29%	BEAT
Q2 '25	$0.72	$0.76	6.22%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

ALCAlcon Inc. - Registered Shares

Upcoming Earnings: Q2 '26

Historical Earnings

Latest ALC News